Literature DB >> 16424061

Age-related changes of the cervix influence human papillomavirus type distribution.

Philip E Castle1, Jose Jeronimo, Mark Schiffman, Rolando Herrero, Ana C Rodríguez, M Concepción Bratti, Allan Hildesheim, Sholom Wacholder, L Rodney Long, Leif Neve, Ruth Pfeiffer, Robert D Burk.   

Abstract

Approximately 15 human papillomavirus (HPV) types cause virtually all cervical cancer whereas other HPV types are unrelated to cancer. We were interested in whether some noncarcinogenic types differ from carcinogenic in their affinity for the cervical transformation zone, where nearly all HPV-induced cancers occur. To examine this possibility, we tested cervical specimens from 8,374 women without cervical precancer and cancer participating in a population-based study in Guanacaste for >40 HPV types using PCR. We compared age-group specific prevalences of HPV types of the alpha9 species, which are mainly carcinogenic and include HPV16, to the genetically distinct types of the alpha3/alpha15 species (e.g., HPV71), which are noncarcinogenic and common in vaginal specimens from hysterectomized women. We related HPV detection of each group to the location of the junction between the squamous epithelium of the ectocervix and vagina and the columnar epithelium of the endocervical canal. Models evaluated the independent effects of amount of exposed columnar epithelium (ectopy) and age on the presence of alpha9 or alpha3/alpha15 types. Prevalence of alpha9 types (7.6%) peaked in the youngest women, declined in middle-aged women, and then increased slightly in older women. By contrast, prevalence of alpha3/alpha15 types (7.6%) tended to remain invariant or to increase with increasing age. Detection of alpha9 infections increased (P(trend) < 0.0005) but alpha3/alpha15 infections decreased (P(trend) < 0.0005) with increasing exposure of the columnar epithelia. Older age and decreasing cervical ectopy were independently positively associated with having an alpha3/alpha15 infection compared with having an alpha9 infection. These patterns need to be confirmed in other studies and populations. We suggest that these genetically distinct groups of HPV types may differ in tissue preferences, which may contribute to their differences in carcinogenic potential.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16424061     DOI: 10.1158/0008-5472.CAN-05-3066

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  40 in total

1.  Early natural history of incident, type-specific human papillomavirus infections in newly sexually active young women.

Authors:  Rachel L Winer; James P Hughes; Qinghua Feng; Long Fu Xi; Stephen Cherne; Sandra O'Reilly; Nancy B Kiviat; Laura A Koutsky
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-12-20       Impact factor: 4.254

Review 2.  Human papillomavirus disease and vaccines in adolescents.

Authors:  Anna-Barbara Moscicki
Journal:  Adolesc Med State Art Rev       Date:  2010-08

3.  Hormonal contraception and area of cervical ectopy: a longitudinal assessment.

Authors:  Patricia L Bright; Abigail Norris Turner; Charles S Morrison; Emelita L Wong; Cynthia Kwok; Irina Yacobson; Rachel A Royce; Heidi O Tucker; Paul D Blumenthal
Journal:  Contraception       Date:  2011-03-23       Impact factor: 3.375

4.  Five-year risks of CIN 2+ and CIN 3+ among women with HPV-positive and HPV-negative LSIL Pap results.

Authors:  Hormuzd A Katki; Mark Schiffman; Philip E Castle; Barbara Fetterman; Nancy E Poitras; Thomas Lorey; Li C Cheung; Tina Raine-Bennett; Julia C Gage; Walter K Kinney
Journal:  J Low Genit Tract Dis       Date:  2013-04       Impact factor: 1.925

5.  Long-term persistence of prevalently detected human papillomavirus infections in the absence of detectable cervical precancer and cancer.

Authors:  Philip E Castle; Ana Cecilia Rodríguez; Robert D Burk; Rolando Herrero; Sholom Wacholder; Allan Hildesheim; Jorge Morales; Greg Rydzak; Mark Schiffman
Journal:  J Infect Dis       Date:  2011-03-15       Impact factor: 5.226

6.  Human papillomavirus types distribution in eastern Sicilian females with cervical lesions. A correlation with colposcopic and histological findings.

Authors:  Maria Le Donne; Giuseppe Giuffrè; Carmela Caruso; Piero Antonio Nicotina; Angela Alibrandi; Rosalba Scalisi; Angela Simone; Benito Chiofalo; Onofrio Triolo
Journal:  Pathol Oncol Res       Date:  2013-02-19       Impact factor: 3.201

7.  Prevalence and risk profile of cervical Human papillomavirus infection in Zhejiang Province, southeast China: a population-based study.

Authors:  Jing Ye; Xiaodong Cheng; Xiaojing Chen; Feng Ye; Weiguo Lü; Xing Xie
Journal:  Virol J       Date:  2010-03-23       Impact factor: 4.099

8.  Risk factors for cervical precancer and cancer in HIV-infected, HPV-positive Rwandan women.

Authors:  Kathryn Anastos; Donald R Hoover; Robert D Burk; Antonio Cajigas; Qiuhu Shi; Diljeet K Singh; Mardge H Cohen; Eugene Mutimura; Charles Sturgis; William C Banzhaf; Philip E Castle
Journal:  PLoS One       Date:  2010-10-20       Impact factor: 3.240

9.  The correlation between human papillomavirus positivity and abnormal cervical cytology result differs by age among perimenopausal women.

Authors:  Anne F Rositch; Michelle I Silver; Anne Burke; Raphael Viscidi; Kathryn Chang; Cindy M P Duke; Wen Shen; Patti E Gravitt
Journal:  J Low Genit Tract Dis       Date:  2013-01       Impact factor: 1.925

10.  Age-specific prevalence of HPV genotypes in cervical cytology samples with equivocal or low-grade lesions.

Authors:  S Brismar-Wendel; M Froberg; A Hjerpe; S Andersson; B Johansson
Journal:  Br J Cancer       Date:  2009-07-21       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.